Amneal Pharmaceuticals, Inc. (AMRX)
16.94
+0.07
(+0.41%)
USD |
NASDAQ |
Sep 11, 14:42
Amneal Pharmaceuticals Gross Profit (TTM) : 1.226B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.226B |
| March 31, 2026 | 1.178B |
| December 31, 2025 | 1.113B |
| September 30, 2025 | 1.079B |
| June 30, 2025 | 1.075B |
| March 31, 2025 | 1.038B |
| December 31, 2024 | 1.020B |
| September 30, 2024 | 983.49M |
| June 30, 2024 | 946.46M |
| March 31, 2024 | 916.54M |
| December 31, 2023 | 856.66M |
| September 30, 2023 | 851.45M |
| June 30, 2023 | 813.82M |
| March 31, 2023 | 799.43M |
| December 31, 2022 | 795.82M |
| September 30, 2022 | 763.51M |
| June 30, 2022 | 767.81M |
| March 31, 2022 | 774.67M |
| December 31, 2021 | 791.66M |
| September 30, 2021 | 770.33M |
| June 30, 2021 | 737.08M |
| March 31, 2021 | 669.58M |
| December 31, 2020 | 662.97M |
| September 30, 2020 | 619.86M |
| June 30, 2020 | 564.47M |
| Date | Value |
|---|---|
| March 31, 2020 | 527.74M |
| December 31, 2019 | 479.16M |
| September 30, 2019 | 549.81M |
| June 30, 2019 | 647.15M |
| March 31, 2019 | 717.18M |
| December 31, 2018 | 725.40M |
| September 30, 2018 | 682.21M |
| June 30, 2018 | 609.32M |
| March 31, 2018 | 554.76M |
| December 31, 2017 | 410.16M |
| September 30, 2017 | 328.12M |
| June 30, 2017 | 298.04M |
| March 31, 2017 | 248.80M |
| December 31, 2016 | 352.78M |
| September 30, 2016 | 398.18M |
| June 30, 2016 | 389.19M |
| March 31, 2016 | 399.56M |
| December 31, 2015 | 354.80M |
| September 30, 2015 | 300.86M |
| June 30, 2015 | 289.34M |
| March 31, 2015 | 314.26M |
| December 31, 2014 | 315.55M |
| September 30, 2014 | 287.65M |
| June 30, 2014 | 264.76M |
| March 31, 2014 | 213.87M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Liquidia Corp. | 416.18M |
| Eli Lilly & Co. | 66.44B |
| Viatris, Inc. | 5.838B |
| Pfizer Inc. | 41.30B |
| Harmony Biosciences Holdings, Inc. | 700.15M |